{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:29:15Z","timestamp":1790886555505,"version":"4.1.0"},"reference-count":42,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974006"],"award-info":[{"award-number":["81974006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Shenkang Hospital","award":["SHDC2020CR2070B"],"award-info":[{"award-number":["SHDC2020CR2070B"]}]},{"name":"Interdisciplinary Program of Shanghai Jiao Tong University","award":["ZH2018ZDB02"],"award-info":[{"award-number":["ZH2018ZDB02"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2023,9,15]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>C-reactive protein (CRP) is a prototypical acute phase protein in humans with the function of regulating immune cells. Serum CRP levels are elevated in multiple myeloma (MM), associated with MM cell proliferation and bone destruction. However, its direct effects on T lymphocytes in MM have not been elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Public data sets were used to explore the correlation of CRP levels with immune cell infiltration and cytotoxicity score of CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in MM. In vitro, repeated freeze-thaw myeloma cell lines were taken as tumor antigens to load dendritic cells (DCs) derived from HLA-A*0201-positive healthy donors. MM-specific cytotoxic T cells (MM-CTL) were obtained from T lymphocytes of the corresponding donors pulsed with these DCs. B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T cells were manipulated by transfecting with lentivirus encoding an anti-BCMA single-chain variable fragment. Then T cells from healthy controls, MM-CTLs and BCMA CAR-T cells were exposed to CRP and analyzed for cell proliferation, cytotoxicity, immunophenotypes. CRP binding capacity to T cells before and after Fc gamma receptors IIb (Fc\u03b3RIIb) blockage, p38 mitogen-activated protein kinase (MAPK) pathway and the downstream molecules were also detected. In vivo, both normal C57BL\/6J mice and the Vk*MYC myeloma mouse models were applied to confirm the impact of CRP on T cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CRP levels were negatively correlated with cell-infiltration and cytotoxicity score of CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in MM. In vitro experiments showed that CRP inhibited T-cell proliferation in a dose-dependent manner, impaired the cytotoxic activity and upregulated expression of senescent markers in CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells. In vivo results validated the suppressive role of CRP in CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells. CRP could bind to CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, mainly to the na\u00efve T subset, while the binding was dramatically decreased by Fc\u03b3RIIb blockage. Furthermore, CRP resulted in increased phosphorylation of p38 MAPK, elevated levels of reactive oxygen species and oxidized glutathione in CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We found that CRP impaired immune response of CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells via Fc\u03b3RIIb-p38MAPK-ROS signaling pathway. The study casted new insights into the role of CRP in anti-myeloma immunity, providing implications for future immunotherapy in MM.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2023-007593","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T13:01:13Z","timestamp":1697461273000},"page":"e007593","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["C-reactive protein impairs immune response of CD8\n                    <sup>+<\/sup>\n                    T cells via Fc\u03b3RIIb-p38MAPK-ROS axis in multiple myeloma"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2109-4822","authenticated-orcid":false,"given":"Jinxing","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Hematology, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0677-8097","authenticated-orcid":false,"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"2025100315300279000_11.10.e007593.1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02607","article-title":"Pentraxins and FC receptor-mediated immune responses","volume":"9","author":"Lu","year":"2018","journal-title":"Front Immunol"},{"key":"2025100315300279000_11.10.e007593.2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595835","article-title":"C-reactive protein and cancer-diagnostic and therapeutic insights","volume":"11","author":"Hart","year":"2020","journal-title":"Front Immunol"},{"key":"2025100315300279000_11.10.e007593.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01162.x"},{"key":"2025100315300279000_11.10.e007593.4","doi-asserted-by":"crossref","unstructured":"Roghanian A , Stopforth RJ , Dahal LN , et al . New revelations from an old receptor: Immunoregulatory functions of the inhibitory FC gamma receptor, Fc\u03b3RIIB (CD32B). J Leukoc Biol 2018. doi:10.1002\/JLB.2MIR0917-354R","DOI":"10.1002\/JLB.2MIR0917-354R"},{"key":"2025100315300279000_11.10.e007593.5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245837","article-title":"The complex role of C-reactive protein in systemic lupus erythematosus","volume":"10","author":"Enocsson","year":"2021","journal-title":"J Clin Med"},{"key":"2025100315300279000_11.10.e007593.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00372","article-title":"C-reactive protein impairs dendritic cell development, maturation, and function: implications for peripheral tolerance","volume":"9","author":"Jimenez","year":"2018","journal-title":"Front Immunol"},{"key":"2025100315300279000_11.10.e007593.7","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200635207"},{"key":"2025100315300279000_11.10.e007593.8","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.243923"},{"key":"2025100315300279000_11.10.e007593.9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402909"},{"key":"2025100315300279000_11.10.e007593.10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000234","article-title":"C reactive protein impairs adaptive immunity in immune cells of patients with melanoma","volume":"8","author":"Yoshida","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2025100315300279000_11.10.e007593.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.08.008"},{"key":"2025100315300279000_11.10.e007593.12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/bmt.2017.228","article-title":"Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation","volume":"53","author":"Chakraborty","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"2025100315300279000_11.10.e007593.13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.05.038","article-title":"Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1\/cytotoxic T-lymphocyte antigen-4 inhibition","volume":"82","author":"Heppt","year":"2017","journal-title":"Eur J Cancer"},{"key":"2025100315300279000_11.10.e007593.14","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.298"},{"key":"2025100315300279000_11.10.e007593.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01740.x"},{"key":"2025100315300279000_11.10.e007593.16","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan6282","article-title":"C-reactive protein promotes bone destruction in human myeloma through the CD32-P38 MAPK-twist axis","volume":"10","author":"Yang","year":"2017","journal-title":"Sci Signal"},{"key":"2025100315300279000_11.10.e007593.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00962-7","article-title":"BCMA-targeted immunotherapy for multiple myeloma","volume":"13","author":"Yu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2025100315300279000_11.10.e007593.18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ajh.26486","article-title":"Anti-CD19 and anti-BCMA car T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma","volume":"97","author":"Shi","year":"2022","journal-title":"Am J Hematol"},{"key":"2025100315300279000_11.10.e007593.19","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1665"},{"key":"2025100315300279000_11.10.e007593.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-023-00971-2","article-title":"Dynamic single-cell RNA-Seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma","volume":"13","author":"Chen","year":"2023","journal-title":"Cell Biosci"},{"key":"2025100315300279000_11.10.e007593.21","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/cas.15800","article-title":"Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma","volume":"114","author":"Jiang","year":"2023","journal-title":"Cancer Sci"},{"key":"2025100315300279000_11.10.e007593.22","article-title":"C-reactive protein: an in-depth look into structure, function, and regulation","volume":"2014","author":"Salazar","year":"2014","journal-title":"Int Sch Res Notices"},{"key":"2025100315300279000_11.10.e007593.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.07.009"},{"key":"2025100315300279000_11.10.e007593.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00410-0"},{"key":"2025100315300279000_11.10.e007593.25","doi-asserted-by":"publisher","DOI":"10.1038\/nri2762"},{"key":"2025100315300279000_11.10.e007593.26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302232"},{"key":"2025100315300279000_11.10.e007593.27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.immuni.2019.12.006","article-title":"Signaling through the inhibitory FC receptor Fc\u03b3RIIB induces CD8+ T cell apoptosis to limit T cell immunity","volume":"52","author":"Morris","year":"2020","journal-title":"Immunity"},{"key":"2025100315300279000_11.10.e007593.28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135623","article-title":"Fc\u03b3RIIB is a T cell checkpoint in antitumor immunity","volume":"6","author":"Farley","year":"2021","journal-title":"JCI Insight"},{"key":"2025100315300279000_11.10.e007593.29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084183","article-title":"Atypical P38 signaling, activation, and implications for disease","volume":"22","author":"Burton","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025100315300279000_11.10.e007593.30","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","article-title":"Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases","volume":"1863","author":"Nakamura","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2025100315300279000_11.10.e007593.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2007.03.010"},{"key":"2025100315300279000_11.10.e007593.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107848"},{"key":"2025100315300279000_11.10.e007593.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.05.004"},{"key":"2025100315300279000_11.10.e007593.34","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1038\/ncomms5229","article-title":"P38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression","volume":"5","author":"Lu","year":"2014","journal-title":"Nat Commun"},{"key":"2025100315300279000_11.10.e007593.35","doi-asserted-by":"crossref","first-page":"109220","DOI":"10.1016\/j.celrep.2021.109220","article-title":"Bacterial genotoxins induce T cell senescence","volume":"35","author":"Mathiasen","year":"2021","journal-title":"Cell Rep"},{"key":"2025100315300279000_11.10.e007593.36","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2981"},{"key":"2025100315300279000_11.10.e007593.37","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070797"},{"key":"2025100315300279000_11.10.e007593.38","doi-asserted-by":"crossref","first-page":"102566","DOI":"10.1016\/j.redox.2022.102566","article-title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/P38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization","volume":"59","author":"Liu","year":"2023","journal-title":"Redox Biol"},{"key":"2025100315300279000_11.10.e007593.39","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.7150\/ijbs.45710","article-title":"Dioscin facilitates ROS-induced apoptosis via the P38-MAPK\/HSP27-mediated pathways in lung squamous cell carcinoma","volume":"16","author":"Yao","year":"2020","journal-title":"Int J Biol Sci"},{"key":"2025100315300279000_11.10.e007593.40","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101957","article-title":"DDIT4 s-Nitrosylation AIDS P38-MAPK signaling complex assembly to promote hepatic reactive oxygen species production","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"2025100315300279000_11.10.e007593.41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-170283","article-title":"Mitochondrial dysfunction triggers synaptic deficits via activation of P38 map kinase signaling in differentiated alzheimer\u2019s disease trans-mitochondrial cybrid cells","volume":"59","author":"Yu","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2025100315300279000_11.10.e007593.42","first-page":"67","article-title":"P38 MAPK and Pi3K\/AKT signalling cascades Inparkinson\u2019s disease","volume":"4","author":"Jha","year":"2015","journal-title":"Int J Mol Cell Med"}],"updated-by":[{"DOI":"10.1136\/jitc-2023-007593corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000}}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-007593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:30:10Z","timestamp":1759530610000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-007593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,16]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/jitc-2023-007593"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-007593","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}